166 related articles for article (PubMed ID: 19541673)
1. Development of generic calcium imaging assay for monitoring Gi-coupled receptors and G-protein interaction.
Ueda T; Ugawa S; Ishida Y; Hondoh A; Shimada S
J Biomol Screen; 2009 Aug; 14(7):781-8. PubMed ID: 19541673
[TBL] [Abstract][Full Text] [Related]
2. D2 dopamine receptor activation of potassium channels is selectively decoupled by Galpha-specific GoLoco motif peptides.
Webb CK; McCudden CR; Willard FS; Kimple RJ; Siderovski DP; Oxford GS
J Neurochem; 2005 Mar; 92(6):1408-18. PubMed ID: 15748159
[TBL] [Abstract][Full Text] [Related]
3. Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors.
Schneider EH; Seifert R
Pharmacol Ther; 2010 Dec; 128(3):387-418. PubMed ID: 20705094
[TBL] [Abstract][Full Text] [Related]
4. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
Lane JR; Powney B; Wise A; Rees S; Milligan G
J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
[TBL] [Abstract][Full Text] [Related]
5. Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3.
Lane JR; Powney B; Wise A; Rees S; Milligan G
Mol Pharmacol; 2007 May; 71(5):1349-59. PubMed ID: 17287401
[TBL] [Abstract][Full Text] [Related]
6. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers.
Schnell D; Burleigh K; Trick J; Seifert R
J Pharmacol Exp Ther; 2010 Mar; 332(3):996-1005. PubMed ID: 19959746
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacology of adrenergic alpha(2C) receptors coupled to Ca(2+) signaling through different Galpha proteins.
Kurko D; Bekes Z; Gere A; Baki A; Boros A; Kolok S; Bugovics G; Nagy J; Szombathelyi Z; Ignácz-Szendrei G
Neurochem Int; 2009 Dec; 55(7):467-75. PubMed ID: 19426776
[TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs.
Hsu SH; Luo CW
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1021-9. PubMed ID: 17652154
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cAMP levels in area CA1 of hippocampus by Gi/o-coupled receptors is stimulus dependent in mice.
Vanhoose AM; Ritchie MD; Winder DG
Neurosci Lett; 2004 Nov; 370(1):80-3. PubMed ID: 15489022
[TBL] [Abstract][Full Text] [Related]
11. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
12. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
Peters MF; Scott CW
J Biomol Screen; 2009 Mar; 14(3):246-55. PubMed ID: 19211780
[TBL] [Abstract][Full Text] [Related]
13. The influence of G protein subtype on agonist action at D2 dopamine receptors.
Nickolls SA; Strange PG
Neuropharmacology; 2004 Nov; 47(6):860-72. PubMed ID: 15527820
[TBL] [Abstract][Full Text] [Related]
14. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
15. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain.
Mannoury la Cour C; El Mestikawy S; Hanoun N; Hamon M; Lanfumey L
Mol Pharmacol; 2006 Sep; 70(3):1013-21. PubMed ID: 16772521
[TBL] [Abstract][Full Text] [Related]
16. A highly conserved glycine within linker I and the extreme C terminus of G protein alpha subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity.
Kostenis E; Martini L; Ellis J; Waldhoer M; Heydorn A; Rosenkilde MM; Norregaard PK; Jorgensen R; Whistler JL; Milligan G
J Pharmacol Exp Ther; 2005 Apr; 313(1):78-87. PubMed ID: 15615862
[TBL] [Abstract][Full Text] [Related]
17. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
Clark MJ; Traynor JR
Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
[TBL] [Abstract][Full Text] [Related]
18. D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.
Vortherms TA; Nguyen CH; Bastepe M; Jüppner H; Watts VJ
Neuropharmacology; 2006 Apr; 50(5):576-84. PubMed ID: 16376953
[TBL] [Abstract][Full Text] [Related]
19. Localization of the mouse 5-hydroxytryptamine(1A) receptor in lipid microdomains depends on its palmitoylation and is involved in receptor-mediated signaling.
Renner U; Glebov K; Lang T; Papusheva E; Balakrishnan S; Keller B; Richter DW; Jahn R; Ponimaskin E
Mol Pharmacol; 2007 Sep; 72(3):502-13. PubMed ID: 17540717
[TBL] [Abstract][Full Text] [Related]
20. Techniques: promiscuous Galpha proteins in basic research and drug discovery.
Kostenis E; Waelbroeck M; Milligan G
Trends Pharmacol Sci; 2005 Nov; 26(11):595-602. PubMed ID: 16183138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
